Public stock analysis · US8636671013
Analyse Stryker stock
StocksterScore94
94.4
Current overview
Metrics for Stryker
Current course246,20 €
StocksterScore94/ 100
Analyst potential+34%
AI price target330,27 €
AI Analysis (Teaser)
AI analysis for Stryker
Plausibility check: confirmed
Current price: 285.40 EUR, Consensus price target: 338.32 EUR, which corresponds to +18.5% potential and is therefore within the required range of +/-25%.
Valuation: With a P/E ratio of 25.77 Stryker is not cheap for a high-quality MedTech stock, but still plausible in the historical and sectoral context. The price target roughly implies a forward multiple in the upper quality segment, which is justifiable due to stable margins, robust cash flows, strong market position and structural growth.
History/Technology: Clearly recovered from the 52W low of EUR 245.59, but still below...
Current price: 285.40 EUR, Consensus price target: 338.32 EUR, which corresponds to +18.5% potential and is therefore within the required range of +/-25%.
Valuation: With a P/E ratio of 25.77 Stryker is not cheap for a high-quality MedTech stock, but still plausible in the historical and sectoral context. The price target roughly implies a forward multiple in the upper quality segment, which is justifiable due to stable margins, robust cash flows, strong market position and structural growth.
History/Technology: Clearly recovered from the 52W low of EUR 245.59, but still below...
AI analysis updated on October 2, 2026